Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 6, 2013, Pages 542-547

  Alevizos, Michail ^a,d   Karagkouni, Anna ^a,e   Vasiadi, Magdalini ^a,b,c   Sismanopoulos, Nikolaos ^a,b,f   Makris, Michael ^b   Kalogeromitros, Dimitrios ^b,g   Theoharides, Theoharis C ^a,b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c TUFTS UNIVERSITY   (United States)

^d Jacobi Medical   (United States)

^e Department of Psychiatry Westchester Hospital   (United States)

^f ST ELIZABETH'S MEDICAL CENTER   (United States)

^g St Elizabeth's Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BETA N ACETYLHEXOSAMINIDASE; DIPHENHYDRAMINE; HISTAMINE; INTERLEUKIN 8; RUPATADINE; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ALLERGIC DISEASE; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG INHIBITION; DRUG MECHANISM; ENZYME RELEASE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ANTI-ALLERGIC AGENTS; BETA-N-ACETYLHEXOSAMINIDASES; CELL LINE, TUMOR; CYPROHEPTADINE; HISTAMINE; HUMANS; INTERLEUKIN-8; MAST CELLS; PLATELET ACTIVATING FACTOR; SUBSTANCE P; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888639375     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.08.025     Document Type: Article

References (47)

1. S.J. Galli, S. Nakae, and M. Tsai Mast cells in the development of adaptive immune responses Nat Immunol 6 2005 135 142
2. Y.A. Mekori, and D.D. Metcalfe Mast cells in innate immunity Immunol Rev 173 2000 131 140
3. J.P. Kinet The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology Annu Rev Immunol 17 1999 931 972
4. T.C. Theoharides, K.D. Alysandratos, and A. Angelidou Mast cells and inflammation Biochim Biophys Acta 1822 2010 21 33
5. K. Kandere-Grzybowska, R. Letourneau, and D. Kempuraj IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells J Immunol 171 2003 4830 4836
6. J. Grabbe, P. Welker, A. Möller, E. Dippel, L.K. Ashman, and B.M. Czarnetzki Comparative cytokine release from human monocytes, monocyte-derived immature mast cells and a human mast cell line (HMC-1) J Invest Dermatol 103 1994 504 508
7. P. Bradding, Y. Okayama, P.H. Howarth, M.K. Church, and S.T. Holgate Heterogeneity of human mast cells based on cytokine content J Immunol 155 1995 297 307
8. S. Krüger-Krasagakes, A.M. Möller, G. Kolde, U. Lippert, M. Weber, and B.M. Henz Production of inteuleukin-6 by human mast cells and basophilic cells J Invest Dermatol 106 1996 75 79
9. B.F. Gibbs, J. Wierecky, P. Welker, B.M. Henz, H.H. Wolff, and J. Grabbe Human skin mast cell rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues Exp Dermatol 10 2001 312 320
10. T.C. Theoharides, D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros Differential release of mast cell mediators and the pathogenesis of inflammation Immunol Rev 217 2007 65 78
11. C.A. Demopoulos, R.N. Pinckard, and D.J. Hanahan Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators) J Biol Chem 254 1979 9355 9358
12. A. Kasperska-Zajac, Z. Brzoza, and B. Rogala Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy Recent Pat Inflamm Allergy Drug Discov 2 2008 72 76
13. A. Kasperska-Zajac, Z. Brzoza, and B. Rogala Platelet activating factor as a mediator and therapeutic approach in bronchial asthma Inflammation 31 2008 112 120
14. P.J. Jenks, G.M. Kavanagh, J. Brooks, J.W. Bradfield, and C.B. Archer Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects Clin Exp Dermatol 24 1999 112 117
15. T.C. Theoharides, S. Enakuaa, and N. Sismanopoulos Contribution of stress to asthma worsening through mast cell activation Ann Allergy Asthma Immunol 109 2012 14 19
16. M. Vasiadi, A. Therianou, and K. Sideri Increased serum CRH levels with decreased skin CRH-R1 gene expression in psoriasis and atopic dermatitis J Allergy Clin Immunol 129 2012 1410 1413
17. D.J. Lenihan, N. Greenberg, and T.C. Lee Involvement of platelet activating factor in physiological stress in the lizard, Anolis carolinensis Comp Biochem Physiol C 81 1985 81 86
18. P. Vadas, M. Gold, and B. Perelman Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis N Engl J Med 358 2008 28 35
19. T. Shibamoto, W. Liu, S. Cui, W. Zhang, H. Takano, and Y. Kurata PAF, rather than histamine, participates in mouse anaphylactic hypotension Pharmacology 82 2008 114 120
20. K. Arias, M. Baig, and M. Colangelo Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions J Allergy Clin Immunol 124 2009 307 314
21. M. Merlos, M. Giral, and D. Balsa Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF) J Pharmacol Exp Therapeut 280 1997 114 121
22. C. Picado Rupatadine: pharmacological profile and its use in the treatment of allergic disorders Expert Opin Pharmacother 7 2006 1989 2001
23. M. Metz, and M. Maurer Rupatadine for the treatment of allergic rhinitis and urticaria Expert Rev Clin Immunol 7 2011 15 20
24. A.S. Kirshenbaum, C. Akin, and Y. Wu Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI Leuk Res 27 2003 677 682
25. N. Kajiwara, T. Sasaki, and P. Bradding Activation of human mast cells through the platelet-activating factor receptor J Allergy Clin Immunol 125 2010 1137 1145
26. Mustafa SB, Pearce FL. Histamine secretion from mast cells stimulated with platelet activating factor (PAF). Agents Actions. 1992;Spec Conf Issue:C65-C67.
27. G. Thomas, and M.K. Church Platelet activating factor does not release histamine from human dispersed cutaneous mast cells Clin Exp Allergy 20 1990 377 382
28. G. Nilsson, D.D. Metcalfe, and D.D. Taub Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response Immunology 99 2000 314 319
29. M. Queralt, P. Brazis, M. Merlos, F. de Mora, and A. Puigdemont In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1 Inflamm Res 49 2000 355 360
30. M. Vasiadi, K. Kalogeromitros, and D. Kempuraj Rupatadine inhibits pro-inflammatory mediator secretion from human mast cells triggered by different stimuli Int Arch Allergy Immunol 151 2010 38 45
31. L. Dubertret, L. Zalupca, and T. Cristodoulo Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study Eur J Dermatol 17 2007 223 228
32. M.K. Church Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males Br J Dermatol 163 2010 1330 1332
33. A. Solans, M.L. Carbo, J. Pena, T. Nadl, I. Izquierdo, and M. Merlos Influence of food on the bioavailability of rupatadine tablets in healthy volunteers; a single-dose, randomized, open-label, two-way crossover study Clin Ther 29 2007 900 908
34. F. Estelle, and R. Simons The antiallergic effects of antihistamines (H1-receptor antagonists) J Allergy Clin Immunol 90 1992 705 715
35. S.J. Keam, and G.L. Plosker Rupatadine: a review of its use in the management of allergic disorders Drugs 67 2007 457 474
36. M. Lytinas, D. Kempuraj, and M. Huang Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells, as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine Allergy Asthma Proc 23 2002 45 51
37. D. Kempuraj, M. Huang, and K. Kandere Azelastine is more potent than olopatadine in inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells Ann Allergy Asthma Immunol 88 2002 501 506
38. D. Kempuraj, M. Huang, and K. Kandere-Grzybowska Azelastine inhibits secretion of IL-6, TNF-α and IL-8 as well as NF-κB activation and intracellular calcium ion levels in normal human mast cells Int Arch Allergy Immunol 132 2003 231 239
39. J.E. Sansom, J. Brooks, J.L. Burton, and C.B. Archer Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin Clin Exp Dermatol 21 1996 33 37
40. D. Abeck, T. Andersson, and E. Grosshans Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis Acta Derm Venereol 77 1997 449 451
41. J. Mullol, J. Bousquet, and C. Bachert Rupatadine in allergic rhinitis and chronic urticaria 1 Allergy 63 suppl 87 2008 5 28
42. P. Stuebner, F. Horak, and R. Zieglmayer Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber Ann Allergy Asthma Immunol 96 2006 37 44
43. F. Siebenhaar, A. Fortsch, and K. Krause Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial Allergy 68 2013 949 952
44. A. Gimenez-Arnau, I. Izquierdo, and M. Maurer The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg J Eur Acad Dermatol Venereol 23 2009 1088 1091
45. C.M. Hogaboam, D. Donigi-Gale, T.S. Shoupe, E.Y. Bissonnette, A.D. Befus, and J.L. Wallace Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds Br J Pharmacol 105 1992 87 92
46. K. Nakajima, M. Murakami, and R. Yanoshita Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor J Biol Chem 272 1997 19708 19713
47. G. Pul-Hidalgo, and L. Bielory Climate change and allergic diseases Ann Allergy Asthma Immunol 109 2012 166 172